Choose from Biotechnology Logo stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Choose from Biotechnology Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

09:38 EDT Portage Biotech (PRTG) trading halted, volatility trading pause Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search ...

The Biotechnology exam for Class 12 is scheduled for March 21, 2025. Students can visit the official website of the CBSE to check sample papers. Here are some of the important questions from CBSE ...

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

Bioprocessing has always been a bit late in adopting the latest engineering techniques, e.g., computational fluid dynamics to ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

The Central Board of Secondary Education (CBSE) is conducting Class 12 Biotechnology exam today, March 21, 2025. The exam will begin at 10.30 am and conclude around 1.30 pm across 7,842 centres in ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.